LUNELLE-1 | Australian Register of Therapeutic Goods | Australia | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

LUNELLE-1
Australia

Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

Contact Supplier

Coral Medroxyprogesterone Acetate

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

jdmfs-not-supported-m-2025-04-28

LUNELLE-1

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 18 USDMF, 7 CEP/COS, 1 JDMF, 5 KDMF, 14 NDC API, 19 Listed Suppliers, $ API Reference Price

40 API Suppliers
18 USDMF
7 CEP/COS
1 JDMF
5 KDMF
14 NDC API
19 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

157 FDF Dossiers, 41 FDA Orange Book, 48 Europe, 14 Canada, 21 Australia, 17 South Africa, 16 Listed Dossiers

157 FDF Dossiers
41 FDA Orange Book
48 Europe
14 Canada
21 Australia
17 South Africa
16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 2.5MG, TABLET;ORAL - 5MG, INJECTABLE;INJECTION - 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 400MG/ML, INJECTABLE;INJECTION - 150MG/ML

TABLET;ORAL - 10MG
TABLET;ORAL - 2.5MG
TABLET;ORAL - 5MG
INJECTABLE;INJECTION - 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 400MG/ML
INJECTABLE;INJECTION - 150MG/ML

RELATED EXCIPIENT COMPANIES

3 Evonik, 4 SPI Pharma, 3 DKSH, 5 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 9 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 27 BASF, 1 Clariant, 3 Corel Pharma Chem, 4 DFE Pharma, 2 Finar, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 20 Kerry, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 15 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 2 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

55 Fillers, Diluents & Binders, 30 Coating Systems & Additives, 26 Solubilizers, 22 Controlled & Modified Release, 21 Thickeners and Stabilizers, 20 Direct Compression, 18 Lubricants & Glidants, 18 Granulation, 16 Topical, 15 Parenteral, 12 Film Formers & Plasticizers, 11 Co-Processed Excipients, 11 Taste Masking, 8 Disintegrants & Superdisintegrants, 5 Chewable & Orodispersible Aids, 5 Emulsifying Agents, 4 Surfactant & Foaming Agents, 3 Coloring Agents, 3 Rheology Modifiers, 1 API Stability Enhancers

55 Fillers, Diluents & Binders
30 Coating Systems & Additives
26 Solubilizers
22 Controlled & Modified Release
21 Thickeners and Stabilizers
20 Direct Compression
18 Lubricants & Glidants
18 Granulation
16 Topical
15 Parenteral
12 Film Formers & Plasticizers
11 Co-Processed Excipients
11 Taste Masking
8 Disintegrants & Superdisintegrants
5 Chewable & Orodispersible Aids
5 Emulsifying Agents
4 Surfactant & Foaming Agents
3 Coloring Agents
3 Rheology Modifiers
1 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 21 News #PharmaBuzz

1 Data Compilation #PharmaFlow
21 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 39 Regulatory FDF Prices

3 US Medicaid Prescriptions
39 Regulatory FDF Prices

MARKET PLACE

8 APIs, 6 FDF Dossiers

8 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 4 Others

3 EDQM
4 Others

$ API Ref.Price (USD/KG) : 923 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

21 All

01 21Pfizer Australia Pty Ltd

filter Active Ingredients Reset all filters

21 All

01 21Medroxyprogesterone

filter Dosage Form Reset all filters

21 All

01 16tablet

02 5Blank

filter Brand Name Reset all filters

21 All

01 1Depo-Provera

02 14Provera

03 6Ralovera

List of Suppliers

Product Main Page

01

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Medroxyprogesterone

Brand Name : Ralovera

Dosage Form : tablet

Dosage Strength : 10 mg

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Medroxyprogesterone

Brand Name : Provera

Dosage Form : tablet

Dosage Strength : 10 mg

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Medroxyprogesterone

Brand Name : Provera

Dosage Form : tablet

Dosage Strength : 200 mg

Packaging : 60

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Medroxyprogesterone

Brand Name : Ralovera

Dosage Form :

Dosage Strength :

Packaging : 100

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Medroxyprogesterone

Brand Name : Provera

Dosage Form :

Dosage Strength :

Packaging : 100

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Medroxyprogesterone

Brand Name : Ralovera

Dosage Form : tablet

Dosage Strength : 5 mg

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Medroxyprogesterone

Brand Name : Provera

Dosage Form : tablet

Dosage Strength : 5 mg

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Medroxyprogesterone

Brand Name : Provera

Dosage Form : tablet

Dosage Strength : 250 mg

Packaging : 60

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Medroxyprogesterone

Brand Name : Provera

Dosage Form : tablet

Dosage Strength : 500 mg

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Pfizer Australia Pty Ltd

RDD 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Medroxyprogesterone

Brand Name : Provera

Dosage Form : tablet

Dosage Strength : 100 mg

Packaging : 100

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!